Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty
- 1 February 2001
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (3) , 330-332
- https://doi.org/10.1016/s0002-9149(00)01368-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Haptoglobin Phenotype and Vascular Complications in Patients with DiabetesNew England Journal of Medicine, 2000
- Haptoglobin Genotype as a Risk Factor for Diabetic RetinopathyJAMA, 2000
- Predicting RestenosisCirculation, 2000
- Oxidation of Low-Density Lipoprotein by Hemoglobin Stems from a Heme-Initiated Globin Radical: Antioxidant Role of HaptoglobinBiochemistry, 1997
- Probucol and Multivitamins in the Prevention of Restenosis after Coronary AngioplastyNew England Journal of Medicine, 1997
- Natural antioxidants and restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1995
- Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis.Circulation, 1993
- Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits.Journal of Clinical Investigation, 1993
- The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Structure and assembly of haptoglobin polymers by electron microscopyJournal of Molecular Biology, 1984